Reviews reflect personal experiences and are not medical advice. Always consult your doctor.
Manufacturer
CHEPLAPHARM ARZNEIMITTEL GMBH
ATC Code
A02BC01
Source
DPD · 02242461
(
ARTG
)
Gastro-Oesophageal Reflux Disease (GORD). 1. Symptomatic GORD. The relief of heartburn and other symptoms associated with GORD. 2. Erosive oesophagitis. The treatment and prevention of relapse. Peptic Ulcers. 1. The treatment of duodenal and gastric ulcer. 2. Combination therapy for the treatment of peptic ulcer disease associated with Helicobacter pylori infections. 3. The treatment of gastric and duodenal ulcers and erosions associated with non-steroidal anti-inflammatory drugs. 4. The prevention of gastric and duodenal ulcers and erosions associated with non-steroidal anti-inflammatory drugs in patients assessed as being at high risk of gastroduodenal ulcer or complications of gastroduodenal ulcer. 5. Long-term prevention of relapse in gastric and duodenal ulceration, in patients proven to be Helicobacter pylori negative, or in whom eradication is inappropriate, e.g. the elderly, or ineffective. Zollinger-Ellison Syndrome. The treatment of Zollinger-Ellison Syndrome.
⚠️ Warnings
(
AHT
)
This medicine contains the active ingredients:
omeprazole
If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on
medication safety for older people
.